Today’s Top Three in Pharma 040909 posted on April 9, 2009Genentech pulls Raptiva from the U.S. market. Risk/benefit ratio got too dicey. AstraZeneca gets a limited approval for Seroquel as add-on treatment for depression. Layoffs + executive raises. Works …Continue Reading about Today’s Top Three in Pharma 040909 →